title: Commentary. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
authors.affiliation: Mote Vascular Foundation, Sarasota, FL 34233, USA. Rsamson@veinandarteries.com
authors.forename: Russell
authors.initials: R
authors.lastname: Samson